Bausch + Lomb Announces New Scientific Data, Educational Events at the European Society of Cataract and Refractive Surgery Annual Congress

  • 30 data presentations and posters include studies evaluating enVista Aspire™, Artelac®* Complete, LuxLife™, enVista Envy™ and ELIOS™ System
  • Multiple events and demonstrations will enable surgeons to hear from top ophthalmologists and engage with the latest Bausch + Lomb technology

VAUGHAN, Ontario, Sept. 3, 2026 – Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and educational events at the European Society of Cataract and Refractive Surgery (ESCRS) annual congress in London, England, Sept. 11-15.

Scientific posters and presentations will highlight the results of studies evaluating Bausch + Lomb technologies including LuxLife™, enVista Aspire™ and enVista Envy™ premium intraocular lenses (IOLs) and the ELIOS™ procedure for the treatment of glaucoma. Sponsored educational events will focus on these and other Bausch + Lomb products.

At the Bausch + Lomb exhibit booth (C.142), the company will feature innovations across its portfolio, including the enVista Envy and LuxLife IOLs, ELIOS, the TENEO™ Excimer Laser Platform and Artelac Complete, during product demonstrations and booth talks. Register here for demonstrations.

Bausch + Lomb is a sponsor of Glaucoma Day, the Excimer Laser Celebration, and iNovation Day, where Chief Executive Officer Brent Saunders will join the “MedTech Leadership Panel,” offering perspectives for the next five years, and Executive Vice President of Research and Development and Chief Medical Officer Yehia Hashad will join another group of industry leaders to discuss “Interventional Glaucoma in the Cataract Practice.” Saunders also will participate in the Ophthalmology Futures Forum leaders panel discussion.

Following is a complete list of Bausch + Lomb events and scientific presentations.

Saturday, September 12, 2026
Satellite Symposium - Redefining the Surgical Experience: Bausch + Lomb’s Fully Integrated Innovative Surgical Suite

  • 13:00-14:00, George V Room 1
  • Speakers: Dr. Robert E. Ang, Dr. Alain Saad, Dr. José Manual Larrosa, Dr. Adam Muzychuk, Dr. Vittorio De Grande
  • Join a panel of experts as they discuss their experience with Bausch + Lomb technologies including the SeeLuma™ iOCT and enVista Envy and share a complete case involving the ELIOS procedure for the treatment of glaucoma and the LuxSmart™ IOL.

Sunday, September 13, 2026
IME Symposium: Simultaneous Vision IOL IME Forum: Achieving Functional Vision – What Is the Right Solution for Today’s Patients?

  • 10:15-11:30, Victoria Room 5/6
  • During the IME symposium, Dr. Belén Alfonso Bartolozzi will present a case study with the enVista Envy IOL.

AI Digital Summit

  • 10:15-12:00, Victoria Room 3
  • During this session, Jay Charnalia, Senior Director, Commercial Ops Surgical & Head of Customer Service Europe, Bausch + Lomb, will present on how the company is providing AI applications to improve doctor practices for today and the immediate future.

Lift Off in London

  • 18:00-22:30. Please register here and receive details about the event and location.
  • During this dynamic and interactive evening, discover the latest Bausch + Lomb Surgical Suite advances while enjoying refreshments and networking with your peers and the Bausch + Lomb team.

Podium Presentations

  • “Visual And Refractive Outcomes Of An Enhanced Monofocal Intraocular Lens In A Prospective, Real World Spanish Multicentre Study.” Castro F.
  • “Effectiveness Of Excimer Laser Trabeculostomy Treatment In Patients With Glaucoma Over 18 Months Of Follow-Up.” De Grande V.
  • “Clinical Outcomes And Patient Satisfaction With A Full Range Of Vision Intraocular Lens: A Single-Centre Prospective Study.” Gaeckle H.
  • “Pre-clinical Evaluation of Glare Phenomena in Presbyopia-Correcting Intraocular Lenses.” Gu S.
  • “Managing Dry Eye Before and After Refractive Surgery.” Labetoulle M.
  • “Clinical Performance of Enhanced Monofocal Intraocular Lenses In Real World Multicenter Study.” McCabe C.
  • “Effectiveness Of The Excimer Laser Trabeculostomy Procedure In Patients With Primary Open-Angle Glaucoma Undergoing Cataract Surgery.” McCabe C.
  • “Visual And Refractive Outcomes From A Multicentric, Prospective Study In Patients Bilaterally Implanted With An Enhanced Monofocal Intraocular Lens.” McCabe C.
  • “A comparison between Mini-Monovision and Bilateral Emmetropia: An assessment of clinical outcomes with an enhanced monofocal intraocular lens.” Micheletti M.
  • “Changes In Visual Field And Peripapillary Retinal Nerve Fibre Layer Thickness After Combined Excimer Laser Trabeculostomy And Phacoemulsification: Five Years of Follow-Up.” Moreno-Valladares A.
  • “Real World Data Of IOP Reduction With Combined Excimer Laser Trabeculostomy And Phacoemulsification At Five Years Of Follow-Up.” Moreno-Valladares A.
  • “Impact Of Residual Refractive Error On Visual Acuity In Eyes Implanted With A Full Visual Range Intraocular Lens.” Muzychuk A.
  • “Assessment Of The Patient-Reported Outcomes Following Bilateral Implantation Of An Enhanced Monofocal Intraocular Lens In Cataract Patients.” Sadri E.
  • “Safety Outcomes Of Excimer Laser Trabeculostomy Performed In Conjunction With Cataract Surgery In Primary Open-Angle Glaucoma Patients.” Singh P.
  • “Acuity, Wavefront, Stereo And Satisfaction Outcomes Of Supracor Transepithelial Phototherapeutic Keratectomy (TransPRK) In Myopic Presbyopes.” Tagal JM.

Posters

  • “Clinical outcomes and eye care practitioner satisfaction with Artelac dry eye lubricating drops in patients with dry eye disease: a retrospective real-world evidence study.” Altroudi W.
  • “Long-Term Follow-Up In A Clinical Study Of Transepithelial Photorefractive Keratectomy Versus Conventional Photorefractive Keratectomy.” Ang R.
  • “Clinical outcomes of an enhanced monofocal intraocular lens in patients with cataract: A real-world study.” Harasymowycz P.
  • “Visual And Safety Outcomes Of Cataract Surgery With A Full Visual Range Intraocular Lens: Real World Evidence Study.” Katz J.
  • “Evaluation Of An Ectoine-Containing Ophthalmic Solution In The Treatment Of Dry Eye Disease.” Labetoulle M. et al.
  • “Visual Performance Of A Full Visual Range, Non-Toric Intraocular Lens Following Cataract Surgery In Routine Clinical Practice.” Muzychuk A.
  • “Real-World Excimer Laser Trabeculostomy Combined With Cataract Surgery In Patients With Primary Open Angle Glaucoma Or Ocular Hypertension: Safety And Effectiveness At 1 Month.” Nijm L.
  • “Performance Of An Enhanced Monofocal IOL: Outcomes Of A Non-Interventional, Prospective, Multicenter Clinical Study.” Parekh J.
  • “Visual And Refractive Outcomes Of A Small Aperture Intraocular Lens In Keratoconic Eyes After Cataract Surgery.” Schartmüller D.
  • “Clinical Outcomes Of Enhanced Monofocal Non-Toric And Toric Intraocular Lenses In Patients Following Cataract Extraction: A Retrospective Case Series.” Stephenson D.
  • “Clinical Performance And Visual Outcomes With A Full Visual Range Toric Intraocular Lens.” Stephenson D.
  • “Clinical Performance And Visual Outcomes Of A Novel Monofocal Plus Intraocular Lens: A Single-Center Experience with The Envista Aspire IOL.” Wowra B.
  • “Early Outcomes Of A Partial Range Of Field Monofocal Intraocular Lens Following Cataract Surgery: A Case Series.” Yau K.
  • “Interim Analysis Of A Multicentre, Retrospective, Real-World Assessment Of the Performance And Safety Of A New Enhanced Intraocular Lens In Patients Undergoing Cataract Surgery.” Leydolt C. et al.
  • “Retrospective real-world evidence study: utilisation patterns and clinical outcomes with two types of lubricating eye drops in patients with dry eye disease.” Wozniak P.

*Not available in the United States.

###

About Bausch + Lomb

Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook , Instagram , LinkedIn , X and YouTube .

Media Contact:
Caryn Marshall
[email protected]
(908) 493-1381

© 2026 Bausch + Lomb.
SRG.0193.USA.26

Back to Press Releases

Media disclaimer example view